HRD detection predicts sensitivity to platinum-based chemotherapy for ovarian cancer patients in China - ecancer
ecancer,
Homologous Recombination Deficiency (HRD) is a biomarker that predicts ovarian cancer treatment with PARP inhibitors or breast…